Digitalization Playful Module of Motor Function Measure Assessment for Children With Neuromuscular Disorders, MFM-Play Pilot Study. (MFM-Play pilot)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04435093|
Recruitment Status : Recruiting
First Posted : June 17, 2020
Last Update Posted : September 25, 2020
The Motor Function Measure (MFM) is a functional rating scale consisting of 32 items assessing motor functional abilities in a person with neuromuscular disease.
By exploring the potential of digital technologies applied to MFM, for each item completion we want to create digital animations containing different playful and informative scenarios. This digital evolution aims to standardize assessment on the therapist's side, but also to improve acceptance of scale and patient participation.
Despite the modification of the MFM completion by digital animation, the study hypothesis is that the metrological qualities of the scale are retained.
Through the MFM-Play pilot study, the objective is to test 5 items of the MFM-Play scale before carrying out a validation study of the total MFM-Play.
|Condition or disease||Intervention/treatment|
|Neuromuscular Diseases||Other: MFM-Play|
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Digitalization Playful Module of Motor Function Measure Assessment for Children With Neuromuscular Disorders, MFM-Play Pilot Study.|
|Actual Study Start Date :||September 21, 2020|
|Estimated Primary Completion Date :||September 21, 2021|
|Estimated Study Completion Date :||September 21, 2021|
Neuromuscular patients will complete five items of the MFM (items 18 to 22) either conventionally or using the MFM-Play with 2 different therapists, on the same day. The order of the MFM type completion will be determined by randomization. Both therapists will rate items 18 to 22 blindly.
- MFM scores item 18 to 22 [ Time Frame: Day 1 ]Level of agreement between the scores obtained during the classic mode and during the MFM-Play mode, completed by two different therapists.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04435093
|Contact: Dominique Vincent-Genod||04 72 12 95 04 ext +firstname.lastname@example.org|
|Contact: Pascal Rippert||04 27 85 63 08 ext +email@example.com|
|Hospices Civils de Lyon||Recruiting|
|Bron, France, 69500|
|Contact: Dominique Vincent-Genod 04 72 12 95 04 ext +33 firstname.lastname@example.org|
|Contact: Pascal Rippert 04 27 85 63 08 ext +33 email@example.com|
|Principal Investigator: Dominique Vincent-Genod|
|CHU de Grenoble||Not yet recruiting|
|La Tronche, France, 38700|
|Contact: Veronique BOURG, MD 04.76.76.75.75 ext +33 firstname.lastname@example.org|
|Principal Investigator: Veronique BOURG, MD|
|CHU Saint Etienne||Not yet recruiting|
|Saint-Étienne, France, 42055|
|Contact: Vincent GAUTHERON, MD 04.77.82.87.29 ext +33 email@example.com|
|Principal Investigator: Vincent GAUTHERON, MD|
|Principal Investigator:||Dominique Vincent-Genod||Hospices Civils de Lyon|